Efficacy endpoints | VARTD (n = 21) |
---|---|
Primary efficacy endpoints | |
Reduction in size of necrotic collection after VARTD, n (%) | |
 ≥ 75% reduction in any axis | 14 (67) |
 ≥ 75% reduction in transverse axis | 13 (62) |
 ≥ 50% reduction in transverse axis | 19 (90) |
 ≥ 75% reduction in AP axis | 9 (43) |
 ≥ 50% reduction in AP axis | 16 (76) |
 Clinical resolution of sepsis or organ dysfunction, n (%) | 21 (100) |
Secondary efficacy endpoint | |
 Repeated interventions for additional drainage/debridement, n (%) | 0 |